Literature DB >> 12594247

Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.

Anna Di Nardo1, Antonella Vitiello, Richard L Gallo.   

Abstract

Cathelicidins (caths) are peptides that are expressed at high levels in neutrophils and some epithelia and can act as natural antibiotics by directly killing a wide range of microorganisms. We hypothesized that caths are expressed in mast cells (MCs), because these cells have been previously associated with inherent antimicrobial activity. Cultured murine MCs contained abundant amounts of cathelin-related antimicrobial peptide (AMP), the murine cath, and this expression was inducible by LPS or lipoteichoic acid. Human skin MCs also expressed cath as detected by immunohistochemical analysis for the human cath LL-37. The functional significance of this expression was shown by comparing MCs cultured from normal mice to MCs from littermates deficient in the cathelin-related AMP gene (Cnlp(-)). MCs derived from Cnlp(-/-) animals had a 50% reduction in their ability to kill group A STREPTOCOCCUS: These MCs expressed equivalent amounts of mRNA for murine beta-defensin-4, a beta-defensin AMP. Thus, different antimicrobials can be identified in MCs, and the presence of cath is necessary for efficient bacterial killing. These observations suggest that the presence of cath is vital to the ability of mammalian MCs to participate in antimicrobial defense.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594247     DOI: 10.4049/jimmunol.170.5.2274

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  115 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

Review 2.  Endogenous production of antimicrobial peptides in innate immunity and human disease.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

Review 3.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

Review 4.  Epithelial antimicrobial defence of the skin and intestine.

Authors:  Richard L Gallo; Lora V Hooper
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

5.  Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses.

Authors:  Zhenping Wang; Daniel T MacLeod; Anna Di Nardo
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

6.  Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttata.

Authors:  Lei Qian; Wei Chen; Wen Sun; Ming Li; Renshan Zheng; Qing Qian; Lianzheng Lv
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

7.  Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.

Authors:  Joanne Domenico; Joseph J Lucas; Mayumi Fujita; Erwin W Gelfand
Journal:  Int Arch Allergy Immunol       Date:  2012-01-26       Impact factor: 2.749

8.  Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens.

Authors:  Marissa H Braff; Mohamed Zaiou; Joshua Fierer; Victor Nizet; Richard L Gallo
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  Defensins and other antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

10.  Staphylococcus colonization of the skin and antimicrobial peptides.

Authors:  Michael Otto
Journal:  Expert Rev Dermatol       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.